Ward Howell sets up its Talent Equity Venture Fund to invest in start-ups valued at up to $5m, working on geographically scalable professional training and HR projects.

TPG Biotech follows on investing in drug development company Trevi Therapeutics, which shares its name with the famous Trevi fountain in Rome (pictured), after backing the company's seed round.

German-based biotech start-up Ayoxxa Biosystems closes a $3.4m Series A round, which is led by Wellington Partners Venture Capital.

Novo Ventures leads a $32m Series A into US-based biotechnology company Allakos for the development of antibody therapeutics for inflammatory diseases, in a round joined by Roche Venture Fund.

Amnon Bar-Lev, the president of network security software company Check Point Software Technologies joins affiliate fund of Greylock Ventures, Greylock Israel Partners, and Norwest Venture participating in a $12m first round of funding for software design storage company ScaleIO.

Relay is joined in the A round by venture firms Hummer Winblad, Lightspeed Venture Partners, New Enterprise Associates, Illuminate Ventures, Resolute.VC, Common Angels, and various angels.

Lundbeckfond Ventures and SR one co-lead a $17m Series A round into US-based River Vision Development Corp, a company managed under contract with Narrow River for developing the drug RV001

Novartis, via its Novartis Venture Funds, participates in a $11m Series A round for cancer treatment company Galera Therapeutics.